NVO
$NVO
Novo Nordisk A/S
Danish pharma giant behind Ozempic and Wegovy weight-loss treatments.
HealthcareSubscribers
2
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
NVO: Valuation Reset Amid Demand Shift
Novo Nordisk ($NVO) is trading at deeply discounted multiples and a high dividend yield following a sharp re-rating. Fundamentals remain strong, but weakening obesity drug demand and data inconsistencies leave the outlook mixed.
Mar 30, 2026